Professional Documents
Culture Documents
DOI 10.1007/s11274-005-9036-x
! Springer 2005
Summary
We previously demonstrated that regulated antisense RNA technology enables us to validate and identify the mode
of action for some antibiotics. In this study, we have expanded the application of the regulated antisense approach
to track the mode of action for a novel inhibitor of polypeptide deformylase (Pdf), which is an attractive target for
the development of novel classes of antibacterial agents. We created a pdf antisense isogenic strain in Staphylococcus
aureus using a TetR-regulated expression system. We demonstrated that the partial inhibition of pdf expression
significantly increased the susceptibility of S. aureus to Pdf-specific inhibitor. This result provides further evidence
that the TetR-regulated antisense technology is a robust tool for tracking the mode of action of novel antibacterial
agents.
Introduction
The recent emergence of multi-drug resistant bacterial
pathogens is generating enormous public health concern. Many of these pathogens are capable of causing
severe and even fatal infections with limited options for
therapy. The slowdown in the discovery of novel classes
of antibiotics in past several decades and the recent
downturn in antibacterial discovery and development in
the pharmaceutical industry is making us more
vulnerable to emerging resistance (Shlaes et al. 2004).
Therefore, there is an urgent need to develop novel,
preventive, and/or therapeutic agents for combating
multi-drug-resistant pathogens. One strategy is to
identify and explore novel molecular targets of the
pathogens (Ji 2002).
Different conditional lethal mutants provide powerful
tools for identifying and characterizing genes essential
for viability in different bacterial systems (Schmid et al.
1989; Geissendorfer & Hillen 1990; Guzman et al. 1995;
Stieger et al. 1999). Regulated promoter-controlled gene
expression strategies have been successfully used to
evaluate drug targets and the mode of action of antibacterial compounds (Zhang et al. 2000; Chan et al.
2003). However, the construction of a regulated promoter-controlled strain in Staphylococcus aureus is very
time-consuming. Recently, DNA microarray techniques
300
J. Yang et al.
We used Escherichia coli DH10B as a host for recombinant plasmids. E. coli DH10B carrying plasmids
pYH4 or pYJ20010 were incubated at 37 "C in LB
medium containing erythromycin (Erm; 300 lg/ml) for
selection. S. aureus RN4220::tetM was used as a host
and grown at 37 "C in tryptic soy broth (TSB)
containing chloramphenicol (10 lg/ml) and tetracycline
(Tc, 0.5 lg/ml). The S. aureus control strain RN4220/
tetM/pYH4 and the antisense isogenic strain JSAS20010
were incubated at 37 "C in TBS containing
erythromycin (5 lg/ml) for selection.
Construction of S. aureus pdf antisense strains
The oligonucleotide primers pdffor (5-TTGGCGC
GCCTGTATGAGTATCTTAACAACCTTTTTAC-3)
and pdfrev (5-TAAATAGGCTTCTTGAACGC-3)
specific for pdf (SA0942 in S. aureus strain N315) were
used to amplify the pdf fragment from S. aureus RN4220
genomic DNA. The bold face sequence in the oligonucleotide primers is the AscI recognition sequence. The
resulting DNA fragments were cloned into pYH4 DNA
in an antisense orientation and resulting in construction
pYJ20010 (pdffor/pdfrev, data not shown). The recombinant plasmid DNA was electroporated into
RN4220/tetM and denoted JSAS20010.
301
Characterization of S. aureus pdf antisense strain
In order to determine whether induced pdf antisense
RNA is sufficient to downregulate endogenous pdf
expression, we characterized the production of transcripts of the pdf fragment in response to Tc induction
and assessed the effects of this induction on Pdf gene
expression.
First, we analysed RNA production from the pdf
antisense strain before and after induction. We found
that in JSAS20010 no detectable pdf antisense RNA was
generated without Tc induction (Figure 2). However,
the pdf antisense strain produced many more pdf antisense RNA products in response to Tc induction
(Figure 2).
Second, we examined the effect of induced pdf antisense RNA on the endogenous pdf expression in order
to determine whether the induced pdf antisense RNA
could cause a significant decrease in the number of Pdf
protein molecules. The whole cell lysate of JSAS20010
without the induction of pdf antisense RNA reacted
strongly with the anti-Pdf antisera (Figure 3); in contrast, following Tc induction, JSAS20010 demonstrated
approximately a10-fold lower reactivity as measured by
densitometer scanning. In addition, the amount of Pdf
in the whole cell lysate of the control strain, RN4220/
pYH4, in the presence of the inducer was similar to that
in the absence of the inducer. These studies demonstrated that induced pdf antisense RNA can significantly
inhibit pdf expression even though the pdf antisense
RNA is not sufficient to cause obvious change of cell
phenotype and growth. One possible explanation is that
levels of the Pdf enzyme significantly lower than those
normally occurring are sufficient for maintaining bacterial survival. The exact reason why a decrease in Pdf
production only delays bacterial growth is unclear; it
might be due to the cumulative effect of Pdf in the
surviving bacterial cells.
302
J. Yang et al.
whether the downregulation of pdf expression by induced pdf antisense RNA is sufficient to increase bacterial susceptibility to Pdf inhibitors. To address this
question, we tested the MIC changes for a synthetic
compound SB220334 using pdf antisense strain
JSAS20010. SB220334 is an actinonin-like molecule
known to inhibit Pdf (Chen et al. 2000) and exhibit
antibacterial activity against S. aureus. As shown in
Table 1, we found that the MIC value of SB220334
significantly decreased 16-fold for JSAS20010 after the
induction of pdf antisense RNA. In contrast, the MIC
values for 35 independent control antimicrobial agents
known not to target Pdf were not changed significantly
Table 1. Antimicrobial activity (MIC values, lg/ml) of antimicrobial compounds against S. aureus with pdf antisense RNA expression
Compound
RN4220/tetM/pYH4 (control)
Tc=0
Tc=500
Tc=1000
Tc=0
Tc=500
Tc=1000
>64
>64
0.5
0.125
1
>64
>64
0.5
0.125
1
>64
>64
0.5
0.125
1
>64
>64
0.25
0.125
1
>64
>64
0.25
0.125
1
>64
>64
0.25
0.125
1
0.125
0.06
0.125
0.06
0.125
0.06
0.125
0.06
0.125
0.06
0.125
0.06
0.125
2
16
0.125
1
>64
1
0.125
2
32
0.125
2
16
0.125
1
>64
1
0.125
1
32
0.125
2
16
0.125
1
>64
1
0.125
1
32
0.125
2
16
0.125
1
>64
0.5
0.125
1
32
0.125
2
8
0.125
1
>64
0.5
0.125
1
32
0.06
2
8
0.125
1
>64
0.25
0.06
0.5
32
64
4
0.015
>64
4
0.25
0.5
32
64
2
0.015
>64
4
0.5
0.5
32
64
1
0.015
>64
4
0.5
0.5
32
64
0.5
0.007
>64
4
0.25
0.5
32
64
0.5
0.007
>64
4
0.25
0.5
32
32
0.25
0.007
>64
4
0.25
0.5
32
32
32
32
32
32
32
64
0.125
64
0.125
64
0.125
64
0.125
64
0.125
64
0.125
>64
>64
>64
>64
>64
>64
1
0.06
0.25
2
1
>64
1
0.06
0.25
2
4
>64
1
0.06
0.25
2
8
>64
1
0.06
0.25
2
1
>64
1
0.06
0.25
2
4
>64
1
0.06
0.25
2
8
>64
16
16
16
16
Acknowledgements
We thank Dr. Martin Burnham for his critical review
and suggestions, Dr. F. Fan for strain RN4220/tetM,
Dr. J. Huang for plasmid DNA pYH4, and Dr. L.
Volker for providing compounds.
References
Bandow, J.E., Brotz, H., Leichert, L.I.O., Labischinski, H. &
Hecker, M. 2003 Proteomic approach to understanding antibiotic
action. Antimicrobial Agents and Chemotherapy 47, 948955.
Chan, P.F., ODwyer, K., Palmer, L., Ambrad, J., Ingraham, K., So,
C., Lonetto, M., Biswas, S., Rosenberg, M., Holmes, D. &
Zalacain, M. 2003 Characterization of a novel fucose-regulated
promoter (PfcsK) suitable for gene essentiality and antibacterial
mode-of action studies in Streptococcus pneumoniae. Journal of
Bacteriology 185, 20512058.
Chang, S.Y., McGary, E.C. & Chang, S. 1989 Methionine aminopeptidase gene of Escherichia coli is essential for bacterial growth.
Journal of Bacteriology 171, 40704072.
303
Chen, D.Z., Petel, D.V., Hackbarth, C.J., Wang, W., Dreyer, G.,
Young, D.C., Margolis, P.S., Wu, C., Ni, Z.J.T.J., White, R.J. &
Yuan, Z. 2000 Actinonin, a naturally occurring antibacterial agent,
is a potent deformylase inhibitor. Biochemistry 39, 12561262.
Forsyth, R.A., Hselbeck, R.J., Ohlesn, K.L., Yamamoto, R.T., Xu,
H., Trawick, J.D., Wall, D., Wang, L., Brown-Driver, V., Froelich,
J.M., Kedar, G.C., King, P., McCarthy, M., Malone, C., Misiner,
B., Robbins, D., Tan, Z., Zhu, Z., Carr, G., Mosca, D.A.,
Zamudio, C., Foulkes, J.G. & Zyskind, J.W. 2002 A genome-wide
strategy for the identification of essential genes in Staphylococcus
aureus. Molecular Microbiology 43, 13871400.
Geissendorfer, M. & Hillen, W. 1990 Regulated expression of heterologous genes in Bacillus subtilis using the Tn10 encoded tet
regulatory elements. Applied Microbiology and Biotechnology 33,
657663.
Guzman, L.M., Belin, D., Calson, M.J. & Beckwith, J. 1995 Tight
regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. Journal of Bacteriology 177,
41214130.
Ji, Y. 2002 The role of genomics in the discovery of novel targets for
antibiotic therapy. Pharmacogenomics 3, 315323.
Ji, Y., Zhang, B., Van Horn, S.F., Warren, P., Woodnutt, G.,
Burnham, M.K.R. & Rosenberg, M. 2001 Identification of critical
staphylococcal genes using conditional phenotypes generated by
antisense RNA. Science 293, 22662269.
Ji, Y., Yin, D., Fox, B., Holmes, D., Payne, D. & Rosenberg, M. 2004
Validation of antibiotic mechanism of action by regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiology Letters 231, 177184.
Khodursky, A.B., Peter, B.J., Schmid, M.B., DeRisi, J., Botstein, D.,
Brown, P.O. & Cozzarelli, N.R. 2000 Analysis of topoisomerase
function in bacterial replication fork movement: use of DNA
microarrays. Proceedings of the National Academy of Sciences of
the USA 97, 94199424.
Schmid, M.B., Kapur, N., Isaacson, D.R., Lindroos, P. & Sharpe, C.
1989 Genetic analysis of temperature-sensitive lethal mutants of
Salmonella typhimurium. Genetics 123, 625633.
Shlaes, D., Projan, S. & Edwards, J. 2004 Antibiotic discovery: state of
the state. ASM News 70, 275281.
Stieger, M., Wohlgensinger, B., Kamber, M., Rolf, L. & Keck, W.
1999 Integrational plasmids for the tetracycline-regulated expression of genes in Streptococcus pneumoniae. Gene 226, 243251.
Yin, D., Fox, B., Lonetto, M.L., Etherton, M.R., Payne, D.J.,
Holmes, D.J., Rosenberg, M. & Ji, Y. 2004 Identification of
antimicrobial targets using a comprehensive genomic approach.
Pharmocogenomics 5, 101113.
Zhang, L., Fan, F., Palmer, L., Lonetto, M., Petit, C., Voelker, L.,
John, A., Bankosky, B., Rosenberg, M. & McDevitt, D. 2000
Regulated gene expression in Staphylococcus aureus for identifying
conditional lethal phenotypes and antibiotic mode of action. Gene
255, 297305.